Advertisement
Actualités Forex
TSX Moves Past 21k Mark To New 52-week High; Resources, Technology Stocks Rise
The Canadian benchmark S&P/TSX Composite Index raced past the 21,000 mark to a fresh 52-week high Wednesday, riding on gains in several sectors.
RTTNews |
il y a 582
U.S. Dollar Drops Against Majors
The U.S. dollar fell against its major counterparts in the New York session on Wednesday.
RTTNews
|
il y a 582
Pound Advances On Rate Cut Expectations
The pound firmed against its major counterparts in the European session on Wednesday, as European stocks rose on hopes that major central banks will lower borrowing costs early next year.
RTTNews
|
il y a 582
Codexis Inks Purchase Deal With Nestle Health Science For CDX-7108
Enzyme engineering company Codexis, Inc. (CDXS) announced Wednesday it has entered into a purchase agreement with Nestle Health Science for CDX-7108, an investigational therapy for the potential treatment of exocrine pancreatic insufficiency (EPI).
RTTNews
|
il y a 582
Surf Air Mobility Appoints Oliver Reeves To Succeed Deanna White As New CFO
Air mobility platform Surf Air Mobility Inc. (SRFM) announced Wednesday that Oliver Reeves will join the Company as Chief Financial Officer. Reeves will lead the Company's financial and capital markets strategies leveraging his nearly two decades of experience in the investment management, enterprise technology, and insurance industries.
RTTNews
|
il y a 582
NKGen Biotech Receives Clearance For SNK01 NK Cell Therapy Clinical Trial From Health Canada
Biotechnology company NKGen Biotech Inc. (NKGN) announced Wednesday that it has received a No Objection Letter from Health Canada for its Clinical Trial Application for a Phase 1/2a study to evaluate the safety, tolerability, and exploratory efficacy of SNK01 natural killer cell therapy for the treatment of patients with moderate Alzheimer's Disease.
RTTNews
|
il y a 582
Zevra Therapeutics Resubmits Arimoclomol NDA To FDA
Zevra Therapeutics, Inc. (ZVRA) announced Wednesday it resubmitted its New Drug Application (NDA) for arimoclomol to the U.S. Food and Drug Administration (FDA) on December 22, 2023. Arimoclomol is an investigational therapeutic candidate for the treatment of Niemann-Pick disease type C (NPC).
RTTNews
|
il y a 582
more news
Hollysys Automation Says 'Go-Shop' Period Under Merger Deal With Ascendent Capital Ends
Hollysys Automation Technologies Ltd. (HOLI) announced Wednesday the end of the "go-shop" period as provided for in the merger agreement with funds managed by Ascendent Capital Partners.
RTTNews
|
il y a 582
FTSE 100 Joins Market Rally Fuelled By Rate Cut Hopes
The FTSE 100 added more than half a percent amidst widespread optimism of an earlier-than-expected rate cut by the Federal Reserve.
RTTNews
|
il y a 582
Rate Cut Hopes Propel CAC-40 Higher
The CAC-40 gained tracking European peers as well as Asian and Wall Street markets that traded on a positive note.
RTTNews
|
il y a 582
First Wave BioPharma To Sell Niclosamide Program To Undisclosed Biopharmaceutical Company
Biopharmaceutical company First Wave BioPharma, Inc. (FWBI) announced Wednesday that it has entered a non-binding term sheet to sell its Niclosamide program for the treatment of inflammatory bowel diseases (IBD) such as ulcerative colitis and related conditions to an undisclosed biopharmaceutical company.
RTTNews
|
il y a 582
DAX Rises As Rate Cut Hopes Strengthen
DAX resumed trading on a positive note after a holiday break. Better-than-expected PCE-based inflation readings from the U.S that bolstered rate cut hopes lifted sentiment at the Frankfurt bourse.
RTTNews
|
il y a 582
Asian Markets Track Wall Street Higher
Renewed rate cut optimism amidst easing inflationary pressures in the U.S. lifted Asian stocks on Wednesday.
RTTNews
|
il y a 582
Stay up to date!
Add Actualités to your browser
Add To Chrome
